Abstract
Benign or pathogenic, microbial biofilms can be found on various viable and inert surfaces, due to the high number of species that are prone to form such multicellular consortia. Biofilm formation can develop on virtually any medical device, representing thus an emerging problem in public health sector because of the increased tolerance to current antimicrobial therapy. With the highest prevalence, bacterial biofilms are also the most intensely studied. In humans, Gram-positive bacterial infections are more prevalent than Gram-negative ones, resulting in biofilm development on the surface of medical devices, facilitated by certain human blood components. Surface of medical devices, regardless of their different synthetic composition could also be colonized by different fungal species, the most recognized fungal infections being those related to Candida species. The rather undocumented or dismissed archaea and protozoan biofilm structures are also relevant for the comprehension of illness setup, and their study could lead to the boost of antibiofilm techniques. Many approaches to obtain biofilm inhibition were developed, but their efficiency is limited by the complex properties of these microbial communities. Hybrid approaches of both classical and modern treatments involving bioactive substances and nanotechnology, materials design, and engineering have been applied in prototype systems aiming to interfere with the virulence of microorganisms, to reduce the adhesion, initiation, and maturation of biofilms.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.